Codon

OCTOBER 13, 2024

Xander Balwit , editor-in-chief of Asimov Press, writes about a restaurant that is bullish on GMOs and other food technology for Issue 04. When one considers the millions of permutations of foods and wines to test, it is easy to see that life is too short for the formulation of dogma. — A.J. Liebling, In Between Meals The facade of Farma in San Francisco.

Engineering 108

Engineering Virus Production DNA 108

Chemical Biology and Drug Design

OCTOBER 13, 2024

This review will provide a comprehensive analysis and outlines various state-of-the-art AI/ML techniques to the readers with their framework applications. This review also highlights the challenges in this field which need to be addressed for further successes in pharmaceutical applications. ABSTRACT The technological revolutions in computers and the advancement of high-throughput screening technologies have driven the application of artificial intelligence (AI) for faster discovery of drug mole

Pharmaceuticals 100

Pharmaceuticals Science Clinical Trials Trials 100

FDA Law Blog: Biosimilars

OCTOBER 13, 2024

By Mark A. Tobolowsky — The Rare Pediatric Disease Priority Review Voucher program has had a bit of a tumultuous history in its 12 short years of existence. Designed to incentivize the development of drugs for pediatric rare diseases where such development may not otherwise have occurred, vouchers may be granted for drugs for serious or life-threatening rare diseases where the serious or life-threatening manifestations primarily affect individuals aged from birth to 18 years.

Disease 64

Disease FDA FDA Approval Government 64

Perficient: Drug Development

OCTOBER 13, 2024

September marked Hunger Action Month (HAM), a time to raise awareness and take action to end hunger. At Perficient India, we took this opportunity to contribute to a cause close to our hearts. The Bangalore team came together in an initiative driven by our Employee Resource Group (ERG), collecting and donating an incredible 1,289.7 pounds of groceries to Ashirwad Sevashram, a home for children in need.

52

52

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials